The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  October 2016 Next
  • 7th RSC / SCI symposium on Kinase inhibitor design

    May 16, 2016   Nottingham, UK

    Closing date for abstract submission is 18th March.

    Perturbation of cell signalling through inhibition of kinase enzymes has delivered nearly 30 approved medicines to date. This symposium will feature several highly pertinent themes including new approaches and technologies to modulate and measure kinase function as well as diverse medicinal chemistry case studies. The symposium will also draw on the lessons from history to provide insight into the future direction of the field.

    Organised by: RSC-BMCS and SCI-FCG

  • 6th RSC / SCI symposium on GPCRs in Medicinal Chemistry

    June 13-15, 2016   Aptuit, Verona, Italy
    Closing date for poster submissions is 29th April.

    The key role of G-protein coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to announce that Aptuit, Italy will support the sixth meeting in this series on GPCR drug discovery, which will combine cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.

    Secretariat Contact
    Maggi Churchouse,
    3 East Barn, Market Weston Road
    Thelnetham, Diss IP22 1JJ, UK
    Telephone and fax: +44 (0)1359 221004
  • 252nd ACS National Meeting & Exposition

    August 21-25, 2016   Philadelphia, Pennsylvania

    Program Theme: Chemistry of the People, by the People and for the People

  • 5th International Symposium on DNA-Encoded Chemical Libraries

    August 26, 2016   ETH Zürich, Switzerland

    Organizers: Dario Neri and Jörg Scheuermann

    Administration: Pia Steinbak -

    Registration: Registration required

    Fees: Attendence is free of charge

  • DSFTM Annual Meeting 2016

    Autumn 2016   Sandberg Gods, Sonderborg
  • FIGON Dutch Medicines Days 2016

    October 2016   to be determinated, probably Ede, The Netherlands

    Contact person:
    Name: Dr Chris de Graaf
    Tel: +31 20 598 75 53
    Fax: +31 20 598 76 10

    co-organised by FIGON & KNCV

  • 5th RSC / SCI symposium on Challenges in Catalysis

    November 2, 2016   The RSC at Burlington House, London, UK

    An exciting programme has been assembled to highlight the current challenges and practices of catalysis science in the Pharmaceutical and Fine Chemicals industries. Topics to be covered will be catalysis in cross-coupling reactions, novel catalytic methods and mechanism, catalysis in flow, novel reactor systems, and automation in catalyst discovery.

    Organised by: RSC-ACG and SCI-FCG

  • Annual Chemistry Learning & Achievement Meeting

    November 3-4, 2016   Lisbon, Portugal

    The Chemistry Consortium of the European Lead Factory annually invites talented EU Lead Factory Chemists from participating SMEs and Academic partners to an annual event that offers opportunities to exchange knowledge gained from their personal research as well as scientific output from the work performed on projects within the EU Lead Factory. The notable advantage of this event for young researchers is the direct visibility of their input and ensuing feedback from peers in the scientific community and participating members of pharmaceutical companies.

    For more information please contact :

  • Water Framework Directive Priority Substances - where should we control them? (Priority Substances III)

    November 15, 2016   Edinburgh Centre for Carbon Innovation, Edinburgh, UK

    This 3rd conference aims to bring together leading EU and UK experts in the field of Priority Substances listed in Annex X of the Water Framework Directive (WFD). The event will discuss issues associated with Priority Substance compliance, where they come from, and where best to control them.  The cost of treating substances is going to be excessive to meet the proposed environmental quality standard limits from the Directive. This conference aims to demonstrate what other approaches are sustainable from cost, environmental, and social perspectives.

  • Plugging the Antibiotics Gap: A Medicinal Chemist's Perspective

    November 16, 2016   Manchester Science Park at Alderley Park, Manchester, UK

    This meeting aims to look at the current state of the art from a medicinal chemist’s perspective and will focus on the particular challenges associated with discovering and developing new antimicrobials. Speakers from industry and academia will describe their own strategies for addressing these challenges whilst showcasing the opportunity for creativity and innovation.

    Organised by: RSC-BMCS and SCI-FCG

  • Late Stage Functionalization for Synthesis and Medicines

    December 5, 2016   University of Oxford, Oxford, United Kingdom

    Late Stage Functionalization (LSF) holds the potential to revolutionise the logic of chemical synthesis and open new ways to prepare novel natural products and medicines. The introduction of important chemical groups for medicinal chemistry in the very last steps of the synthesis through LSF could also dramatically speed up the preparation of NCEs and have a major impact on drug discovery. The availability of new powerful catalytic chemistries showing a high degree of functional group tolerance and that can be performed under mild conditions offer tremendous opportunities for chemists to access new molecules that cannot be made easily by conventional approaches.

  • Protein-Protein Interactions 2016

    December 5-6, 2016   SCI, London, United Kingdom

    This meeting will address recent advances in the characterisation and identification of new PPI inhibitors. Topics will include: in silico assessment of PPI druggability, assay screening technologies for PPIs, structural biology approaches and fragment based drug design. Both industry and academia will describe strategies for addressing these challenges whilst showcasing the opportunity for creativity and innovation.

  • 10th BMCS Biological and Medicinal Chemistry Postgraduate Symposium

    December 16, 2016   University of Cambridge, Cambridge, UK

    The Biological and Medicinal Chemistry Sector (BMCS) of the RSC will be hosting its tenth postgraduate symposium for PhD students and postdoctoral workers researching in biological or medicinal chemistry and related areas. Researchers working in these areas are invited to participate.

    Contact person: Dave Alker


  • Frontiers in Medicinal Chemistry

    February 12-15, 2017    Bern, Switzerland

    The international symposium will focus on current developments, novel approaches and cutting-edge technologies in the field of medicinal chemistry and drug research with sessions on Chemical Biology, Computer-Aided Drug Design, Protein Degradation, Immuno-oncology and Immunomodulation, Drugs for the treatment of liver diseases, and Highlights in Medicinal Chemistry. The scientific program will include lectures, and poster presentations. It is the goal of the organizers to make this meeting an event of scientific excellence, attractive to both industrial and academic scientists in Medicinal Chemistry, Chemical Biology, and related fields of research.

    Contact person: Prof. Dr. Jean-Louis Reymond


  • International Symposium “Molecular Imaging Agents in Medicine”

    February 13-15, 2017   Groningen, The Netherlands

    For more information please visit:

  • 6th RSC-BMCS Fragment-based Drug Discovery Meeting

    March 5-7, 2017   ParkHotel, Schönbrunn, Vienna, Austria

    The aim of this meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. The conference will include successful examples from all types of fragment-based approaches, including high concentration, NMR, SPR and X-ray screening.

  • The BMCS Mastering MedChem III: 3rd RSC-BMCS Symposium on Mastering Medicinal Chemistry

    March 22, 2017   Life Sciences Hub, Cardiff, UK

    This meeting is aimed at all those who wish to become better drug hunters and heed warnings from the past. In the main there are two types of drug discovery programmes: those that hit serious problems and those that are going to hit serious problems. The difference between success and failure is how we, as medicinal chemists, tackle and resolve the problems.

  • 3rd Agriscience Chemical Biology Postgraduate Symposium

    March 31, 2017   Imperial College, London, UK

    The 3rd symposium for PhD and postdoctoral students undertaking chemical biology research in areas related to agriculture and the agrisciences. Chemical biology in this context is referring to physical sciences tools and technologies (in chemistry, physics, mathematics and engineering) which are being applied to tackle biological problems on a molecular level. All students and researchers utilizing a combination of chemistry and fungal, insect or plant biology in their research projects, from any UK or European university, are invited to attend.

  • 253rd ACS National Meeting & Exposition

    April 2-6, 2017   San Francisco, California

  • 28th Hatfield symposium on Medicinal Chemistry in Eastern England

    April 27, 2017   The Fielder Centre, Hatfield, UK

  • 2nd Transporters in Drug Discovery and Development

    May 15-16, 2017   RSC at Burlington House, London, UK

    Cell surface transporters play a key role in human health and disease, both through their impact on drug disposition and as therapeutic targets in their own right. This meeting should be of interest to medicinal chemists, DMPK scientists and other workers with interests on the impact of transporters on human health.

  • 17th Hellenic Symposium on Medicinal Chemistry

    June 1-3, 2017   Aristotle University of Thessaloniki, Greece

    HSMC-17 continues the tradition of biannual meetings established since 30 years in Greece as a forum for the discussion of recent advances in the field of Medicinal Chemistry. The topics of the Symposium include Drug Design and lead identification and optimization, ADME/Tox properties in drug discovery, Advances in Synthetic Medicinal Chemistry, Natural Products, Chemical Biology, Pharmacology, Computational Chemistry, Chemoinformatics / Pharmaco-informatics, Pharmaceutical Analysis and –omics in Pharmaceutical Sciences are integrated to create the environment for fruitful interchange of ideas between scientists involved in Medicinal Chemistry related areas.

    Contact person: Prof. Dr Athina Geronikaki


    Organised by : Hellenic Society of Medicinal Chemistry (Greece)

  • Medicinal Chemistry Residential School

    June 11-16, 2017   Loughborough, United Kingdom

    The Royal Society of Chemistry Medicinal Chemistry Residential School will cover topics of interest to drug discovery researchers, helping to increase understanding of the factors governing modern drug discovery from the initial concept through to translational science and intellectual property. Established since 1981, our Residential School has trained many of the world’s leading medicinal chemists working in the pharmaceutical industry and academic research institutes.

    Who should attend?

    The school is designed for graduate and post-doctoral chemists with 1-5 years’ experience in the field of drug research. Drug discovery is an interdisciplinary subject so delegates from biological or computational backgrounds will benefit from attendance at the school.
    In addition, final year PhD students from pharmaceutical or organic chemistry contemplating a career in drug discovery are also encouraged to attend.

    Course content

    The course includes the following topics:

    •     Target Validation
    •     Computational Chemistry
    •     Biological Mechanisms
    •     Pharmacokinetics and Drug Metabolism
    •     Screening of New Compounds
    •     Patents
    •     Molecular Biology in Medicinal Chemistry
    •     Exploiting a Chemical Lead
    •     Combinatorial Chemistry and Molecular Diversity
    •     Case Histories of Drug Discovery
    •     Toxicology in Drug Discovery
    •     Pharmaceutical Considerations in Drug Development
    •     Structure-guided Drug Design
    •     Physical Properties and Quantitative Structure-Activity Relationships
    •     Hints and Tips in Medicinal Chemistry

    Course organisers

    Dr Andy Davis (Course Leader) AstraZeneca, United Kingdom
    Dr Simon Ward (Course Leader) University of Sussex, United Kingdom
    Dr Kathleen Too, Royal Society of Chemistry, United Kingdom

    Key deadlines

    Poster abstract deadline: 7 May 2017
    Early bird registration: 9 April 2017
    Standard registration: 7 May 2017

  • 1st RSC Anglo-Nordic MedChem Symposium

    June 12-14, 2017   Hotel Comwell Borupgaard, Snekkersten, Denmark

    The scientific programme will feature classical and contemporary themed lectures, focusing on medicinal chemistry and related technologies and disciplines across a range of drug targets and modalities. A distinguishing feature of this symposium is the collegiate conference style which encourages an atmosphere of information sharing and learning.

  • 2nd Symposium on Medicinal Chemistry for World Health

    June 18-19, 2017   Tres Cantos, Spain

    Bringing together leading exponents for an exciting spread of themed sessions, the meeting will appeal to anyone with an interest in drug discovery and medicinal chemistry. With great opportunities for collaborative academic–industrial partnerships and open innovation discovery programmes, researchers from both sectors will benefit from the networking opportunities that the meeting will also offer.

  • 2nd RSC Chemistry in Energy Conference

    July 17-19, 2017   University of Sheffield, Sheffield, UK

    The purpose of this conference is to bring together scientists and technologists from academia and industry with interests in the applications of Chemistry in the Energy Industry. This second event aims to embrace all aspects of energy–related research, where chemistry and the chemical sciences play a key or underpinning role in solving the UK’s combined energy challenges of carbon emissions, energy costs and security of supply.

  • RACI National Centenary Conference 2017

    July 23-28, 2017   Melbourne, Australia

    The RACI National Centenary Conference will be planned alongside the 17th Asian Chemical Congress to cover any subject matter areas not covered by our seven international speciality partner meetings to ensure the complete event will cover all the major areas of the chemical sciences.

    For more information please contact:

    RACI Centenary Conference Secretariat


  • AIMECS 2017: Chemistry in Drug Discovery, Design & Development

    July 23-27, 2017   Melbourne Australia

  • 254th ACS National Meeting & Exposition

    August 20-24, 2017   Washington, DC

  • 7th Cambridge Symposium on Nucleic Acids Chemistry and Biology

    September 3-6, 2017   Queens' College, Cambridge, UK

    This is the 7th in a popular conference series going back to 1981 that brings together nucleic acids scientists across a broad area but with particular emphasis on chemistry, biochemistry and structure. Subject areas include nucleic acids as therapeutics, RNA and DNA structures and their protein complexes, nucleic acids chemistry applied to cells and cell mechanisms, and nucleic acids as tools, structural assemblies and devices.

  • 19th RSC / SCI Medicinal Chemistry Symposium

    September 10-13, 2017   Churchill College, Cambridge, UK

    Reflecting current trends in medicinal chemistry and pharmaceutical research, the scientific programme will feature lectures on the full range of drug targets, key enabling processes and technologies together with late breaker talks. Furthermore, one session will be dedicated to neglected tropical diseases including a planned live webcast that will be recorded for further distribution.

  • 255th ACS National Meeting & Exposition

    March 18-22, 2018   New Orleans, Louisiana

  • 256th ACS National Meeting & Exposition

    August 19-23, 2018   Boston, Massachusetts

  • 257th ACS National Meeting & Exposition

    March 31-April 4, 2019   Orlando, Florida

  • 258th ACS National Meeting & Exposition

    August 25-29, 2019   San Diego, California

  • 259th ACS National Meeting & Exposition

    March 22-26, 2020   Philadelphia, Pennsylvania

  • 260th ACS National Meeting & Exposition

    August 23 - 27, 2020   San Francisco. California

  • 261st ACS National Meeting & Exposition

    March 21 - 25, 2021   San Antonio, Texas

  • 262nd ACS National Meeting & Exposition

    August 22-26, 2021   Atlanta, Georgia

  • 263rd ACS National Meeting & Exposition

    March 20-24, 2022   San Diego, California

  • 264th ACS National Meeting & Exposition

    August 21-25, 2022   Chicago, Illinois

  • 265th ACS National Meeting & Exposition

    March 26-30, 2023   Indianapolis, Indiana

  • 266th ACS National Meeting & Exposition

    August 13-17, 2023   San Francisco, California

  • 267th ACS National Meeting & Exposition

    March 17-21, 2024   New Orleans, Louisianna

  • 269th ACS National Meeting & Exposition

    March 23-27, 2025   San Diego, California

  • 270th ACS National Meeting & Exposition

    August 17-21, 2025   Washington, District of Columbia

26 27 28 29 30 01 02
03 04 05 06 07 08 09
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31 01 02 03 04 05 06
All events   |  Future events

Job portal

Junior Group Leader, Institut Curie: Chemical Biology of Membranes and Therapeutic Delivery Unit, Paris, France
read more

Job portal page

Follow us on Twitter

Follow us on LinkedIn

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck